- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Key Takeaways From ASCRS 2025: Understanding Recent Data for Treating Dry Eye Disease
A panelist discusses how recent clinical studies on dry eye disease emphasize the importance of precise diagnosis and targeted treatments such as cyclosporine formulations and varenicline nasal spray in improving tear film stability, reducing inflammation, and enhancing patient outcomes, while highlighting challenges such as delayed symptom relief, medication adherence, and the need for ongoing research into meibomian gland dysfunction.
EP. 1: Dry Eye Disease: Pathophysiology, Impact, and Standard of Care
June 13th 2025A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment while acknowledging ongoing challenges with patient expectations, medication access, delayed symptom relief, and treatment adherence.
Watch
